Merck and Co Inc (A Company Incorporated In the United States of America) v Generics (UK) Limited: ChD 27 Nov 2003

Action for infringement of a relating to a method of making a compound called 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid monosodium salt trihydrate, that is to say the monosodium salt of alendronic acid, more commonly called monosodium alendronate

The Hon Mr Justice Laddie
[2003] EWHC 2842 (Pat), [2004] RPC 31
Bailii
England and Wales

Intellectual Property

Updated: 13 December 2021; Ref: scu.188273